Source: BioPortfolio

Eli Lilly: US court upholds validity of Teva's Ajovy patents

The US Patent Trial and Appeal Board has rejected Eli Lilly's appeal against the validity of Teva's patents for its migraine treatment.

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Based on data from Eli Lilly's latest SEC filings

Annual Revenue

Based on data from Eli Lilly's latest SEC filings

Employees

David A. Ricks's photo - Chairman & CEO of Eli Lilly

Chairman & CEO

David A. Ricks

CEO Approval Rating

69/100

Eli Lilly develops, produces and markets pharmaceutical products for health care professionals, patients and consumers.

E...
Read more